Retraction
Efficacy and Safety of Peginterferon α-2a and Entecavir Tenofovir in the Treatment of Chronic Hepatitis B Genotype C
Paper Information
Retraction Details
Retraction Reasons:
- Concerns/Issues About Data
- Concerns/Issues about Results and/or Conclusions
- Concerns/Issues about Referencing/Attributions
- Concerns/Issues with Peer Review
- Investigation by Journal/Publisher
- Investigation by Third Party
- Computer-Aided Content or Computer-Generated Content
- Unreliable Results and/or Conclusions
Nature of Retraction:
Retraction
Retraction Notice:
10.1155/2023/9895013Additional Notes:
See also: https://pubpeer.com/publications/AC9CB9F9CE2376443B98AF5B14A2BB
Citations (3)
3
Total Citations1
Post-Retraction(33.3%)
0
Pre-Retraction1
Same DayPost-Retraction Citation Analysis
0
Within 30 days
0
Within 1 year
0
After 2+ years
369
Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Systematic review with network meta-analysis: sustained hepatitis B surface antigen clearance after pegylated interferon cessation
Ying Zhang, Xiaoyu Lin, Huizhen Wu et al. (5 authors)
European Journal of Gastroenterology & Hepatology
Published: Jul 2024
369 days after retraction
Retracted: Efficacy and Safety of Peginterferon α-2a and Entecavir Tenofovir in the Treatment of Chronic Hepatitis B Genotype C
Contrast Media Molecular Imaging
Contrast Media & Molecular Imaging
Open Access
Published: Jul 2023
Same day as retraction
Quick Stats
Total Citations:
4
Years Since Retraction:
2.3 years
Open Access:
Yes
Last Checked:
Jul 24, 2025